The RAF (acronym for rapidly accelerated fibrosarcoma) kinases are a family of related Ser/Thr kinases that are important for normal cellular and physiological processes, but are also associated with oncogenesis [6]. They are components of the Ras-Raf-MAPK signalling pathway.

1. Chin PC, Liu L, Morrison BE, Siddiq A, Ratan RR, Bottiglieri T, D'Mello SR. (2004) The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. J Neurochem, 90 (3): 595-608. [PMID:15255937]

2. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

3. Hansen JD, Grina J, Newhouse B, Welch M, Topalov G, Littman N, Callejo M, Gloor S, Martinson M, Laird E et al.. (2008) Potent and selective pyrazole-based inhibitors of B-Raf kinase. Bioorg Med Chem Lett, 18 (16): 4692-5. [PMID:18676143]

4. Horbert R, Pinchuk B, Davies P, Alessi D, Peifer C. (2015) Photoactivatable Prodrugs of Antimelanoma Agent Vemurafenib. ACS Chem Biol, 10 (9): 2099-107. [PMID:26061392]

5. Laquerre S, Arnone M, Moss K, Yang J, Fisher K, Kane-Carson LS, Smitheman K, Ward J, Heidrich B, Rheault T et al. (2009) Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B-RafV600E mutation. Mol Cancer Ther, 8 (12) Meeting Abstract.

6. Leicht DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M, Tzivion G. (2007) Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta, 1773 (8): 1196-212. [PMID:17555829]

7. Wang X, Kim J. (2012) Conformation-specific effects of Raf kinase inhibitors. J Med Chem, 55 (17): 7332-41. [PMID:22808911]

8. Zambon A, Niculescu-Duvaz I, Niculescu-Duvaz D, Marais R, Springer CJ. (2012) Small molecule inhibitors of BRAF in clinical trials. Bioorg Med Chem Lett, 22 (2): 789-92. [PMID:22222036]